Form 4 for ARTV Artiva Biotherapeutics, Inc.
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-15 · accession 0001193125-25-285005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-17 | 2025-11-15 | ARTV | Krishnamohan Neha | CFO | F - Tax | $3.25 | -3,490 | 99.4K | -3% | -$11.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-15 | F | D | 3,490 | $3.25 | 99,356 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. |